Asset
Tapentadol hydrochloride
Collegium Pharmaceutical Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (3)
| Application | Type | Applicant |
|---|---|---|
| NDA 022304 | NDA | COLLEGIUM PHARMACEUTICAL INC |
| NDA 200533 | NDA | COLLEGIUM PHARMACEUTICAL INC |
| NDA 203794 | NDA | COLLEGIUM PHARMACEUTICAL INC |
Marketed products (9)
- NUCYNTA
- NUCYNTA
- NUCYNTA
- NUCYNTA
- NUCYNTA ER
- NUCYNTA ER
- NUCYNTA ER
- NUCYNTA ER
- NUCYNTA ER